MENLO PARK, Calif., July 05, 2017 -- Landec Corporation (Nasdaq:LNDC) will hold a conference call on Wednesday, July 26, 2017 at 8 a.m. Pacific time to discuss its results for the fiscal fourth quarter and fiscal year-end 2017. Financial results will be reported for the 2017 fiscal fourth quarter and fiscal year ended May 28, 2017 after market close on July 25, 2017.
Landec's President and CEO, Molly Hemmeter, will host the Conference Call with Gregory S. Skinner, Vice President and CFO. A question and answer period will follow the presentation.
Date: Wednesday, July 26, 2017
Time: 8 a.m. Pacific time (11 a.m. Eastern time)
Toll Free Participant Dial-in Number: (844) 860-6243
U.S. and International Toll Number: (661) 378-9884
Conference ID: 45958252
Webcast: http://ir.Landec.com/events.cfm
The webcast will be available for 30 days through August 25, 2017.
A replay of the teleconference will be available for one week until midnight Eastern time, Wednesday, August 2, 2017
Toll free replay dial in: (855) 859-2056
International replay: (404) 537-3406
Replay passcode: 45958252
About Landec Corporation
Landec Corporation (NASDAQ:LNDC) is a leading innovator of diversified health and wellness solutions within the packaged natural food and biomaterial markets. Apio, Landec's food business, is the leader in branded, packaged fresh vegetables in North America, utilizing its proprietary BreatheWay® packaging technology to naturally extend the shelf life of fresh produce. Apio combines this technology with the capabilities of a large national fresh produce supplier to offer healthy fresh vegetable products under the Eat Smart® brand to consumers through club and retail grocery stores. Extending its reach into adjacent natural food products outside of produce, Landec recently acquired O Olive Oil, Inc., an organic and natural producer and marketer of olive oils and vinegars under the O brand. Lifecore Biomedical, Landec’s biomaterial business, is a fully integrated Contract Development and Manufacturing Organization (CDMO) that offers expertise and capabilities in fermentation, specialty formulation, aseptic filling and final packaging for FDA regulated medical devices and drugs to customers for applications in a wide array of markets including Ophthalmic, Orthopedic and Oncology. For more information about the company, visit Landec’s website at www.landec.com.
CONTACT: Media and Industry Contact: At the Company: Gregory S. Skinner Vice President Finance and CFO (650) 261-3677 Investor Relations: ICR, Inc. John Mills, Partner (646) 277-1254 [email protected]


Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover
Samsung Electronics Posts Eightfold Profit Surge Driven by AI Chip Demand
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Deere & Company Agrees to $99 Million Settlement Over Right-to-Repair Dispute
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Apple Turns 50: From Garage Startup to AI Crossroads
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
First Western Ship Transits Strait of Hormuz Since Iran War Began
SpaceX IPO: Retail Investors to Play Historic Role in Record-Breaking Public Offering
UPS and Teamsters Reach Agreement to Limit Driver Severance Program 



